Granules, Laurus Labs to invest Rs 700 crores for setting up Greenfield facilities
Rama Rao thanked the leadership of both the companies for choosing to invest in Telangana and said the state government would provide all possible support to them.
Hyderabad: Two city-based pharma companies- Granules India and Laurus Labs on Tuesday separately announced major investments in Genome Valley here.
Granules India said it would be setting up a facility with a capacity to manufacture 10 billion units of finished dosages at an investment of Rs 400 crore The proposed unit would generate employment for about 1,600 people, an official release from Industries Minister K T Rama Raos office said.
Laurus Labs, a leading research driven Pharmaceutical Manufacturing Company, announced setting up of a formulation Facility with a unit capacity of 5 billion.
The company plans to invest Rs 300 crores in two phases of Rs 150 crore each.
Phase one of the plant is expected to provide employment to about 150 people, it said.
Granules India has manufacturing sites in eight locations and presence in 75 countries.
The company already operates the world's largest Commercial Pharmaceutical Formulation Intermediates (PFI) Facility at nearby Gagillapur.
Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India Ltd, met Rama Rao on Tuesday to formally make this announcement, it said.
Satyanarayana Chava, CEO, Laurus Labs, also separately met the Industries Minister today, along with his team before making the announcement.
Industries Department Principal Secretary Jayesh Ranjan was also present in the meeting.
Rama Rao thanked the leadership of both the companies for choosing to invest in Telangana and said the state government would provide all possible support to them.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.